New

Disclosing Tablets Market

2021

Disclosing Tablets Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Composition(Iodine, Fluorescein, and Erythrosine); Age Group(children, adults, and geriatric population); Distribution Channel (online (e-commerce) and medical pharmacies) and Geography

| Report Code: TIPRE00025964 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

Market Insights

Disclosing Tablets Market 2028 By Composition, Age Group, Distribution Channel and medical pharmacies) and Geography | The Insight Partners

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET OVERVIEW

The component of a drug that produces the desired effects is known as the active pharmaceutical ingredient (API). Combination therapies, for example, in long term treatments have various active substances that cure different symptoms or act in different ways. API is the potent component in drug formulation and often used with additives or excipients to improve therapeutic efficacy of a medicine. Many pharmaceutial companies develop their API by own or by outsourcing operations. Some common examples of API are, diclofenac, propanolol, methotraxate etc.

MARKET SCOPE

The "Global Active Pharmaceutical Ingredient (API) Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the active pharmaceutical ingredient (API) market with detailed market segmentation by type of synthesis and therapeutic application. The report provides key statistics on the market status of the leading active pharmaceutical ingredient (API) market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

  •   Based on type of synthesis the market is bifurcated as, biotech and synthetic.
  •   Based on therapeutic application the market is segmented as, cardiology, oncology, CNS and neurology, orthopedic, endocrinology, pulmonology, gastroenterology, nephrology, ophthalmology and others.


MARKET DYNAMICS
Drivers:

  •   Significant growth in pharmaceutical & biotechnology companies.
  •   Growth in R&D activities across the companies to develop novel molecules and APIs.
  •   Increasing prevalnece of chronic diseases, idiosyncratic diseases and advancements in API production activities.

Restraints:

  •   Issues such as higher manufacturing costs and time consuming method of API development.
  •   Unfavorable DPCO guidelines are also expected to restrain market growth.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The Active pharmaceutical ingredient (API) market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the Active pharmaceutical ingredient (API) market in these regions.

IMPACT OF COVID-19 ON ACTIVE PHARMACEUTICAL INGREDIENT (API) MARKET

COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. But some of the API molecules such as, remdesivir, favipiravir, and other such API have shown promising outcomes against covid-19 infection which has impacted positively on API market growth however, COVID-19 has disrupted all the business and economic activities across the globe which is expected to have some impact on active pharmaceutical ingredient (API) market. According to the current market situation, the report further assesses the present and future effects of the COVID-19 pandemic on the overall market, giving more reliable and authentic projections In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the Active pharmaceutical ingredient (API) market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from Active pharmaceutical ingredient (API) market are anticipated to lucrative growth opportunities in the future with the rising demand for Active pharmaceutical ingredient (API) in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the Active pharmaceutical ingredient (API) market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  •   Teva Pharmaceutical Industries Ltd.
  •   AbbVie Inc.
  •   Pfizer, Inc.
  •   Cipla Inc.
  •   Merck KGaA
  •   Bristol Myers Squibb
  •   GlaxoSmithKline plc
  •   Mylan N.V.
  •   Dr. Reddy's Laboratories Ltd
  •   Sun Pharmaceutical Industries Ltd
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Single -Use Clinical Thermometer - By Product Type
1.3.2 Single -Use Clinical Thermometer - By Target Area
1.3.3 Single -Use Clinical Thermometer - By End-User
1.3.4 Single -Use Clinical Thermometer - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. SINGLE -USE CLINICAL THERMOMETER LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. SINGLE -USE CLINICAL THERMOMETER - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. SINGLE -USE CLINICAL THERMOMETER - GLOBAL MARKET ANALYSIS
6.1. SINGLE -USE CLINICAL THERMOMETER - GLOBAL MARKET OVERVIEW
6.2. SINGLE -USE CLINICAL THERMOMETER - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING
7. SINGLE -USE CLINICAL THERMOMETER - REVENUE AND FORECASTS TO 2028 - PRODUCT TYPE
7.1. OVERVIEW
7.2. PRODUCT TYPE MARKET FORECASTS AND ANALYSIS
7.3. MERCURY THERMOMETERS
7.3.1. Overview
7.3.2. Mercury Thermometers Market Forecast and Analysis
7.4. DIGITAL THERMOMETERS
7.4.1. Overview
7.4.2. Digital Thermometers Market Forecast and Analysis
7.5. STRIP THERMOMETERS
7.5.1. Overview
7.5.2. Strip Thermometers Market Forecast and Analysis
8. SINGLE -USE CLINICAL THERMOMETER - REVENUE AND FORECASTS TO 2028 - TARGET AREA
8.1. OVERVIEW
8.2. TARGET AREA MARKET FORECASTS AND ANALYSIS
8.3. ORAL
8.3.1. Overview
8.3.2. Oral Market Forecast and Analysis
8.4. AXILLA
8.4.1. Overview
8.4.2. Axilla Market Forecast and Analysis
8.5. RECTAL
8.5.1. Overview
8.5.2. Rectal Market Forecast and Analysis
8.6. OTHERS
8.6.1. Overview
8.6.2. Others Market Forecast and Analysis
9. SINGLE -USE CLINICAL THERMOMETER - REVENUE AND FORECASTS TO 2028 - END-USER
9.1. OVERVIEW
9.2. END-USER MARKET FORECASTS AND ANALYSIS
9.3. HOSPITALS
9.3.1. Overview
9.3.2. Hospitals Market Forecast and Analysis
9.4. HOMECARE SETTINGS
9.4.1. Overview
9.4.2. Homecare Settings Market Forecast and Analysis
9.5. DIAGNOSTIC CENTERS
9.5.1. Overview
9.5.2. Diagnostic Centers Market Forecast and Analysis
9.6. OTHERS
9.6.1. Overview
9.6.2. Others Market Forecast and Analysis
10. SINGLE -USE CLINICAL THERMOMETER REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Single -Use Clinical Thermometer Overview
10.1.2 North America Single -Use Clinical Thermometer Forecasts and Analysis
10.1.3 North America Single -Use Clinical Thermometer Forecasts and Analysis - By Product Type
10.1.4 North America Single -Use Clinical Thermometer Forecasts and Analysis - By Target Area
10.1.5 North America Single -Use Clinical Thermometer Forecasts and Analysis - By End-User
10.1.6 North America Single -Use Clinical Thermometer Forecasts and Analysis - By Countries
10.1.6.1 United States Single -Use Clinical Thermometer
10.1.6.1.1 United States Single -Use Clinical Thermometer by Product Type
10.1.6.1.2 United States Single -Use Clinical Thermometer by Target Area
10.1.6.1.3 United States Single -Use Clinical Thermometer by End-User
10.1.6.2 Canada Single -Use Clinical Thermometer
10.1.6.2.1 Canada Single -Use Clinical Thermometer by Product Type
10.1.6.2.2 Canada Single -Use Clinical Thermometer by Target Area
10.1.6.2.3 Canada Single -Use Clinical Thermometer by End-User
10.1.6.3 Mexico Single -Use Clinical Thermometer
10.1.6.3.1 Mexico Single -Use Clinical Thermometer by Product Type
10.1.6.3.2 Mexico Single -Use Clinical Thermometer by Target Area
10.1.6.3.3 Mexico Single -Use Clinical Thermometer by End-User
10.2. EUROPE
10.2.1 Europe Single -Use Clinical Thermometer Overview
10.2.2 Europe Single -Use Clinical Thermometer Forecasts and Analysis
10.2.3 Europe Single -Use Clinical Thermometer Forecasts and Analysis - By Product Type
10.2.4 Europe Single -Use Clinical Thermometer Forecasts and Analysis - By Target Area
10.2.5 Europe Single -Use Clinical Thermometer Forecasts and Analysis - By End-User
10.2.6 Europe Single -Use Clinical Thermometer Forecasts and Analysis - By Countries
10.2.6.1 Germany Single -Use Clinical Thermometer
10.2.6.1.1 Germany Single -Use Clinical Thermometer by Product Type
10.2.6.1.2 Germany Single -Use Clinical Thermometer by Target Area
10.2.6.1.3 Germany Single -Use Clinical Thermometer by End-User
10.2.6.2 France Single -Use Clinical Thermometer
10.2.6.2.1 France Single -Use Clinical Thermometer by Product Type
10.2.6.2.2 France Single -Use Clinical Thermometer by Target Area
10.2.6.2.3 France Single -Use Clinical Thermometer by End-User
10.2.6.3 Italy Single -Use Clinical Thermometer
10.2.6.3.1 Italy Single -Use Clinical Thermometer by Product Type
10.2.6.3.2 Italy Single -Use Clinical Thermometer by Target Area
10.2.6.3.3 Italy Single -Use Clinical Thermometer by End-User
10.2.6.4 Spain Single -Use Clinical Thermometer
10.2.6.4.1 Spain Single -Use Clinical Thermometer by Product Type
10.2.6.4.2 Spain Single -Use Clinical Thermometer by Target Area
10.2.6.4.3 Spain Single -Use Clinical Thermometer by End-User
10.2.6.5 United Kingdom Single -Use Clinical Thermometer
10.2.6.5.1 United Kingdom Single -Use Clinical Thermometer by Product Type
10.2.6.5.2 United Kingdom Single -Use Clinical Thermometer by Target Area
10.2.6.5.3 United Kingdom Single -Use Clinical Thermometer by End-User
10.2.6.6 Rest of Europe Single -Use Clinical Thermometer
10.2.6.6.1 Rest of Europe Single -Use Clinical Thermometer by Product Type
10.2.6.6.2 Rest of Europe Single -Use Clinical Thermometer by Target Area
10.2.6.6.3 Rest of Europe Single -Use Clinical Thermometer by End-User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Single -Use Clinical Thermometer Overview
10.3.2 Asia-Pacific Single -Use Clinical Thermometer Forecasts and Analysis
10.3.3 Asia-Pacific Single -Use Clinical Thermometer Forecasts and Analysis - By Product Type
10.3.4 Asia-Pacific Single -Use Clinical Thermometer Forecasts and Analysis - By Target Area
10.3.5 Asia-Pacific Single -Use Clinical Thermometer Forecasts and Analysis - By End-User
10.3.6 Asia-Pacific Single -Use Clinical Thermometer Forecasts and Analysis - By Countries
10.3.6.1 Australia Single -Use Clinical Thermometer
10.3.6.1.1 Australia Single -Use Clinical Thermometer by Product Type
10.3.6.1.2 Australia Single -Use Clinical Thermometer by Target Area
10.3.6.1.3 Australia Single -Use Clinical Thermometer by End-User
10.3.6.2 China Single -Use Clinical Thermometer
10.3.6.2.1 China Single -Use Clinical Thermometer by Product Type
10.3.6.2.2 China Single -Use Clinical Thermometer by Target Area
10.3.6.2.3 China Single -Use Clinical Thermometer by End-User
10.3.6.3 India Single -Use Clinical Thermometer
10.3.6.3.1 India Single -Use Clinical Thermometer by Product Type
10.3.6.3.2 India Single -Use Clinical Thermometer by Target Area
10.3.6.3.3 India Single -Use Clinical Thermometer by End-User
10.3.6.4 Japan Single -Use Clinical Thermometer
10.3.6.4.1 Japan Single -Use Clinical Thermometer by Product Type
10.3.6.4.2 Japan Single -Use Clinical Thermometer by Target Area
10.3.6.4.3 Japan Single -Use Clinical Thermometer by End-User
10.3.6.5 South Korea Single -Use Clinical Thermometer
10.3.6.5.1 South Korea Single -Use Clinical Thermometer by Product Type
10.3.6.5.2 South Korea Single -Use Clinical Thermometer by Target Area
10.3.6.5.3 South Korea Single -Use Clinical Thermometer by End-User
10.3.6.6 Rest of Asia-Pacific Single -Use Clinical Thermometer
10.3.6.6.1 Rest of Asia-Pacific Single -Use Clinical Thermometer by Product Type
10.3.6.6.2 Rest of Asia-Pacific Single -Use Clinical Thermometer by Target Area
10.3.6.6.3 Rest of Asia-Pacific Single -Use Clinical Thermometer by End-User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Single -Use Clinical Thermometer Overview
10.4.2 Middle East and Africa Single -Use Clinical Thermometer Forecasts and Analysis
10.4.3 Middle East and Africa Single -Use Clinical Thermometer Forecasts and Analysis - By Product Type
10.4.4 Middle East and Africa Single -Use Clinical Thermometer Forecasts and Analysis - By Target Area
10.4.5 Middle East and Africa Single -Use Clinical Thermometer Forecasts and Analysis - By End-User
10.4.6 Middle East and Africa Single -Use Clinical Thermometer Forecasts and Analysis - By Countries
10.4.6.1 South Africa Single -Use Clinical Thermometer
10.4.6.1.1 South Africa Single -Use Clinical Thermometer by Product Type
10.4.6.1.2 South Africa Single -Use Clinical Thermometer by Target Area
10.4.6.1.3 South Africa Single -Use Clinical Thermometer by End-User
10.4.6.2 Saudi Arabia Single -Use Clinical Thermometer
10.4.6.2.1 Saudi Arabia Single -Use Clinical Thermometer by Product Type
10.4.6.2.2 Saudi Arabia Single -Use Clinical Thermometer by Target Area
10.4.6.2.3 Saudi Arabia Single -Use Clinical Thermometer by End-User
10.4.6.3 U.A.E Single -Use Clinical Thermometer
10.4.6.3.1 U.A.E Single -Use Clinical Thermometer by Product Type
10.4.6.3.2 U.A.E Single -Use Clinical Thermometer by Target Area
10.4.6.3.3 U.A.E Single -Use Clinical Thermometer by End-User
10.4.6.4 Rest of Middle East and Africa Single -Use Clinical Thermometer
10.4.6.4.1 Rest of Middle East and Africa Single -Use Clinical Thermometer by Product Type
10.4.6.4.2 Rest of Middle East and Africa Single -Use Clinical Thermometer by Target Area
10.4.6.4.3 Rest of Middle East and Africa Single -Use Clinical Thermometer by End-User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Single -Use Clinical Thermometer Overview
10.5.2 South and Central America Single -Use Clinical Thermometer Forecasts and Analysis
10.5.3 South and Central America Single -Use Clinical Thermometer Forecasts and Analysis - By Product Type
10.5.4 South and Central America Single -Use Clinical Thermometer Forecasts and Analysis - By Target Area
10.5.5 South and Central America Single -Use Clinical Thermometer Forecasts and Analysis - By End-User
10.5.6 South and Central America Single -Use Clinical Thermometer Forecasts and Analysis - By Countries
10.5.6.1 Brazil Single -Use Clinical Thermometer
10.5.6.1.1 Brazil Single -Use Clinical Thermometer by Product Type
10.5.6.1.2 Brazil Single -Use Clinical Thermometer by Target Area
10.5.6.1.3 Brazil Single -Use Clinical Thermometer by End-User
10.5.6.2 Argentina Single -Use Clinical Thermometer
10.5.6.2.1 Argentina Single -Use Clinical Thermometer by Product Type
10.5.6.2.2 Argentina Single -Use Clinical Thermometer by Target Area
10.5.6.2.3 Argentina Single -Use Clinical Thermometer by End-User
10.5.6.3 Rest of South and Central America Single -Use Clinical Thermometer
10.5.6.3.1 Rest of South and Central America Single -Use Clinical Thermometer by Product Type
10.5.6.3.2 Rest of South and Central America Single -Use Clinical Thermometer by Target Area
10.5.6.3.3 Rest of South and Central America Single -Use Clinical Thermometer by End-User
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL SINGLE -USE CLINICAL THERMOMETER
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Middle East and Africa
11.5 South and Central America
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. SINGLE -USE CLINICAL THERMOMETER, KEY COMPANY PROFILES
13.1. GF HEALTH PRODUCTS, INC. ("GRAHAM-FIELD")
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. ACME UNITED CORPORATION
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. MEDICAL INDICATORS
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. 3M
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. TEMPAGENIX AND TEMP-N-TOSS
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. MEDLINE INDUSTRIES, INC.
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. GH ZEAL LTD.
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. FISCHER SCIENTIFIC (PART OF THERMO FISCHER SCIENTIFIC)
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. HOPKINS MEDICAL PRODUCTS
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. THOMAS PUBLISHING COMPANY
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS

13.8.6. Key Developments
13.9. SUNSTAR GROUP
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. PLAQUEHD
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies

- Procter & Gamble
- The Boots Company PLC.
- Sunstar Suisse S.A.
- TEPE INTERNATIONAL
- PRODUITS DENTAIRES SA
- Dent-O-Care
- Colgate-Palmolive Company
- Young Innovations GmbH
- Sunstar Group
- PlaqueHD
TIPRE00025964
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking
Request for Sample
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.